Skip to main content
2023 IKCS: Europe Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

SESSION 2: Understanding Renal Cell Carcinoma

Phase II study of nivolumab and salvage nivolumab + ipilimumab in RCC (HCRN GU16-260): Correlative Results

Friday, April 21, 2023
10:37 – 10:47 GMT

    Speaker(s)

  • Michael B. Atkins, MD (he/him/his)

    Vice Chair of Department of Medical Oncology
    Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
    Georgetown-Lombardi Comprehensive Cancer Center
    WAshington, District of Columbia, United States

    Slides